This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Skinner, M A Articles by Matthews, T J Search for Related Content PubMed PubMed Citation Articles by Skinner, M A Articles by Matthews, T J

 Previous Article  |  Next Article 

J Virol. 1988 November; 62(11): 4195-4200

Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4.

Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710.

ABSTRACT

Animals immunized with the human immunodeficiency virus type 1 gp160 glycoprotein or certain recombinant envelope components develop potent virus-neutralizing activity. This activity is principally due to antibodies directed toward a hypervariable region of gp120 between cysteine residues 302 and 337 and is virus isolate specific. These antisera, as well as two neutralizing monoclonal antibodies directed against the same hypervariable sequence, do not appreciably block gp120 from binding CD4. In contrast, serum samples from infected humans possess high titers of antibodies that block gp120-CD4 binding; these titers approximately correlate with the serum neutralization titers. Our results suggest that there are at least two targets on the envelope glycoprotein for virus neutralization. The target responsible for the broader neutralizing activity of human serum may be a conserved region of gp120 involved in CD4 binding. The antibodies directed at the hypervariable region of the envelope inhibit a different step in virus infection which is subsequent to receptor binding. The extent to which these two different epitopes of gp120 may be involved in protection against human immunodeficiency virus infection is discussed.

This article has been cited by other articles:

• Jinno-Oue, A., Shimizu, N., Soda, Y., Tanaka, A., Ohtsuki, T., Kurosaki, D., Suzuki, Y., Hoshino, H. (2005). The Synthetic Peptide Derived from the NH2-terminal Extracellular Region of an Orphan G Protein-coupled Receptor, GPR1, Preferentially Inhibits Infection of X4 HIV-1. J. Biol. Chem. 280: 30924-30934 [Abstract] [Full Text]  
• Zwick, M. B., Kelleher, R., Jensen, R., Labrijn, A. F., Wang, M., Quinnan, G. V. Jr., Parren, P. W. H. I., Burton, D. R. (2003). A Novel Human Antibody against Human Immunodeficiency Virus Type 1 gp120 Is V1, V2, and V3 Loop Dependent and Helps Delimit the Epitope of the Broadly Neutralizing Antibody Immunoglobulin G1 b12. J. Virol. 77: 6965-6978 [Abstract] [Full Text]  
• Kilby, J. M., Eron, J. J. (2003). Novel Therapies Based on Mechanisms of HIV-1 Cell Entry. NEJM 348: 2228-2238 [Full Text]  
• Srivastava, I. K., Stamatatos, L., Legg, H., Kan, E., Fong, A., Coates, S. R., Leung, L., Wininger, M., Donnelly, J. J., Ulmer, J. B., Barnett, S. W. (2002). Purification and Characterization of Oligomeric Envelope Glycoprotein from a Primary R5 Subtype B Human Immunodeficiency Virus. J. Virol. 76: 2835-2847 [Abstract] [Full Text]  
• Taguchi, F., Shimazaki, Y. K. (2000). Functional analysis of an epitope in the S2 subunit of the murine coronavirus spike protein: involvement in fusion activity. J. Gen. Virol. 81: 2867-2871 [Abstract] [Full Text]  
• Ugolini, S., Mondor, I., Parren, P. W.H.I., Burton, D. R., Tilley, S. A., Klasse, P. J., Sattentau, Q. J. (1997). Inhibition of Virus Attachment to CD4+ Target Cells Is a Major Mechanism of T Cell Line-adapted HIV-1 Neutralization. J. Exp. Med. 186: 1287-1298 [Abstract] [Full Text]  
• Esté, J. A., Schols, D., De Vreese, K., Van Laethem, K., Vandamme, A.-M., Desmyter, J., De Clercq, E. (1997). Development of Resistance of Human Immunodeficiency Virus Type 1 to Dextran Sulfate Associated with the Emergence of Specific Mutations in the Envelope gp120 Glycoprotein. Mol. Pharmacol. 52: 98-104 [Abstract] [Full Text]  
• Freed, E. O., Martin, M. A. (1995). The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection. J. Biol. Chem. 270: 23883-23886 [Full Text]  
• Ghiara, J., Stura, E., Stanfield, R., Profy, A., Wilson, I. (1994). Crystal structure of the principal neutralization site of HIV-1. Science 264: 82-85 [Abstract]  
• Hwang, S., Boyle, T., Lyerly, H., Cullen, B. (1992). Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1. Science 257: 535-537 [Abstract]  
• Hwang, S., Boyle, T., Lyerly, H., Cullen, B. (1991). Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253: 71-74 [Abstract]